Piper Sandler lowered the firm’s price target on Moderna (MRNA) to $69 from $115 and keeps an Overweight rating on the shares. The firm notes ...
Applied Materials tumbles after issuing a disappointing fiscal first-quarter outlook, Palantir is transferring its stock listing to the Nasdaq, and Tesla rises following a decline on worries President ...
Monolithic Power Systems, Inc. MPWR lost 24.68% last week as it was hit by an Edgewater Research analyst report that stated ...
HSBC upgraded Moderna (MRNA) to Hold from Reduce with a $58 price target Don't Miss our Black Friday Offers:Discover the latest stocks ...
Here are some of the major companies whose stocks moved on the week’s news.
Shares of Moderna Inc. (NASDAQ: MRNA) are trading lower after President-elect Donald Trump nominated Robert F. Kennedy Jr. to ...
Short interest for healthcare stocks in S&P 500 stayed flat in October vs. September, while Moderna continued to be most ...